Cleared Traditional

K061131 - DBX-H HEMOSTATIC DEMINERALIZED BONE MATRIX PUTTY

K061131 is an FDA 510(k) clearance for DBX-H HEMOSTATIC DEMINERALIZED BONE MAT..., manufactured by Orthocon, Inc.. The device is a Class 2 Orthopedic device with product code MBP cleared through the Traditional 510(k) pathway after a 290-day FDA review.

K061131 · Orthocon, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2007
Decision
290d
Days
Class 2
Risk

K061131 is an FDA 510(k) clearance for the DBX-H HEMOSTATIC DEMINERALIZED BONE MATRIX PUTTY. Classified as Filler, Bone Void, Osteoinduction (w/o Human Growth Factor) (product code MBP), Class II - Special Controls.

Submitted by Orthocon, Inc. (Colts Neck, US). The FDA issued a Cleared decision on February 8, 2007 after a review of 290 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Orthocon, Inc. devices

FDA 510(k) Submission Details - K061131

510(k) Number K061131 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 24, 2006
Decision Date February 08, 2007
Days to Decision 290 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
168d slower than avg
Panel avg: 122d · This submission: 290d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MBP Device Classification - Class 2, Special Controls

Product Code MBP Filler, Bone Void, Osteoinduction (w/o Human Growth Factor)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MBP Filler, Bone Void, Osteoinduction (w/o Human Growth Factor)

All 19
Devices cleared under the same product code (MBP) and FDA review panel - the closest regulatory comparables to K061131.
SYGNAL DBM
K073329 · Musculoskeletal Transplant Foundation · Feb 2008
OPTECURE
K063685 · Exactech, Inc. · Jun 2007
DBX DEMINERALIZED BONE MATRIX MIX
K063676 · Musculoskeletal Transplant Foundation · Mar 2007
PLEXUR P
K061982 · Osteotech, Inc. · Feb 2007
DBX STRIP
K062205 · Musculoskeletal Transplant Foundation · Feb 2007
PROGENIX DBM PUTTY AND PASTE
K060794 · Medtronic Sofamor Danek · Dec 2006